Area of research
Cellular and Molecular Neuroscience · Infectious Diseases
Research interest
Research interests include Neuroscience and Neuropharmacology Research, Autoimmune Neurological Disorders and Treatments, SARS-CoV-2 and COVID-19 Research, and Cellular transport and secretion.
Patient-derived monoclonal LGI1 autoantibodies elicit seizures, behavioral changes and brain MRI abnormalities in rodent models
Biallelic <i>LGI1</i> and <i>ADAM23</i> variants cause hippocampal epileptic encephalopathy via the LGI1–ADAM22/23 pathway
Oligodendrocyte-derived LGI3 and its receptor ADAM23 organize juxtaparanodal Kv1 channel clustering for short-term synaptic plasticity
Brain blood vessel autoantibodies in patients with NMDA and GABAA receptor encephalitis: identification of unconventional Myosin-X as target antigen
SARS-CoV-2 Beta variant infection elicits potent lineage-specific and cross-reactive antibodies
LGI1–ADAM22–MAGUK configures transsynaptic nanoalignment for synaptic transmission and epilepsy prevention
A combination of cross-neutralizing antibodies synergizes to prevent SARS-CoV-2 and SARS-CoV pseudovirus infection
Encephalitis patient-derived monoclonal GABAA receptor antibodies cause epileptic seizures.
A Therapeutic Non-self-reactive SARS-CoV-2 Antibody Protects from Lung Pathology in a COVID-19 Hamster Model
Human gestational <i>N</i>‐methyl‐<scp>d</scp>‐aspartate receptor autoantibodies impair neonatal murine brain function
Bi-allelic Variants in IQSEC1 Cause Intellectual Disability, Developmental Delay, and Short Stature